Dr. Pandy Opima is a Director Study Leader within Early Oncology R&D at AstraZeneca, and has held positions of increasing responsibilities during the past several years.

Born and raised in Uganda, Dr. Opima is very passionate about finding ways to address health disparities within underserved populations, and has been advocating for clinical trial diversity since joining AstraZeneca in 2015.

In 2020, he joined the Chief Medical Office as a secondment Clinical Trial Diversity Project Lead, where he supported the CMO to lead a team comprised of cross functional volunteers in the development of a strategy and tactics focused on enhancing CTD at AZ. He is also involved in collaborations with other organizations such as PhRMA, TransCelerate, and NMQF to enhance CTD across the clinical trial ecosystem.

He holds a Medical Degree in Stomatology, MPH in Epidemiology, and MBA in Global Management and is using his 30 years of medical, public health, and pharmaceutical experience, in supporting his efforts to improve health equity.